Omeros Corporation
OMER
#6930
Rank
NZ$1.18 B
Marketcap
NZ$16.36
Share price
-1.04%
Change (1 day)
169.65%
Change (1 year)

Omeros Corporation (OMER) - Cash on Hand

Cash on Hand as of March 2026 : NZ$0.23 Billion

According to Omeros Corporation's latest financial reports the company has NZ$0.23 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Omeros Corporation - Cash on Hand chart (from 2008 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31NZ$0.29 B85.62%
2024-12-31NZ$0.15 B-41.19%
2023-12-31NZ$0.27 B-11.49%
2022-12-31NZ$0.30 B33.34%
2021-12-31NZ$0.23 B23.1%
2020-12-31NZ$0.18 B107.22%
2019-12-31NZ$90.25 M0.08%
2018-12-31NZ$90.19 M-23.52%
2017-12-31NZ$0.11 B80.19%
2016-12-31NZ$65.44 M58.47%
2015-12-31NZ$41.29 M369.87%
2014-12-31NZ$8.78 M-48.78%
2013-12-31NZ$17.15 M-36.84%
2012-12-31NZ$27.16 M-13.7%
2011-12-31NZ$31.48 M-42.16%
2010-12-31NZ$54.43 M-34.44%
2009-12-31NZ$83.02 M141.13%
2008-12-31NZ$34.43 M9.52%
2007-12-31NZ$31.43 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
NZ$37.85 B 16,195.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$22.44 B 9,562.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
NZ$1.17 M-99.50%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Eterna Therapeutics
ERNA
NZ$15.75 M-93.22%๐Ÿ‡บ๐Ÿ‡ธ USA